Manufacturing
Healthcare
Pharmaceutical

BioPharmX

$0.0927
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0055 (-5.60%) Today
-$0.0055 (-5.60%) Today

Why Robinhood?

You can buy or sell BioPharmX and other stocks, options, ETFs, and crypto commission-free!

About

BioPharmX Corp. engages in the provision of healthcare products through platform technologies for pharmaceutical, over-the-counter, and supplement applications in dermatology. Its platforms include Topical Gel, Injectable, and Encapsulation. Read More The company was founded by James R. Pekarsky and Anja B. Krammer on August 30, 2010 and is headquartered in Menlo Park, CA.

Employees
17
Headquarters
San Jose, California
Founded
2010
Market Cap
21.44M
Price-Earnings Ratio
β€”
Dividend Yield
0.00
Average Volume
4.74M
High Today
$0.0988
Low Today
$0.0925
Open Price
$0.098
Volume
2.29M
52 Week High
$0.294
52 Week Low
$0.05

Collections

Manufacturing
Healthcare
Pharmaceutical
Health
2014 IPO
US
North America

News

PR NewswireMar 21

BioPharmX Announces $3.9 Million Offering

SAN JOSE, Calif., March 21, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 43,645,000 shares of common stock at a price of $0.09 per share in a registered direct offering. The gross proceeds of the offering are expected to be approximately $3.9 million. Ne...

4,008
Markets InsiderMar 18

BioPharmX to Participate in the 31st Annual ROTH Conference and the Oppenheimer 29th Annual Healthcare Conference

SAN JOSE, Calif., March 18, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced presentations at multiple upcoming investor conferences. President and CEO Dr. David S. Tierney will present the latest company overview at: The 31 st Annual ROTH Conference on Monday, March 18 at 8:30am Pacific Time in Laguna Niguel, CA. Annual ROTH Conference on at in The Oppenheimer 29th Annual He...

10,480
MarketBeatMar 16

Stock Price, News, & Analysis for Biopharmx

BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets.

294

Earnings

-$0.06
-$0.04
-$0.03
-$0.01
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
β€”
Actual
-$0.01 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.